Back
to sessions
Sep 29
Quick Pitch
MODERATOR(S)
Michael Goldstein, MD, PhD - Johns Hopkins School of Medicine
Alan Dal Pra, MD - University of Miami - Sylvester Comprehensive Cancer Center
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
05:00pm - 05:05pm ETSpeaker: Alan Dal Pra, MD - University of Miami - Sylvester Comprehensive Cancer Center, Miami
-
05:05pm - 05:10pm ET
Beyond NCCN: How a Prognostic and Predictive Multimodal AI Biomarker Drives ADT De-Escalation In Prostate Cancer
Speaker: Eric Wegener, MBBS - Genesis Cancer Care, Newcastle -
05:10pm - 05:15pm ET
Deep Genomic and Pathologic Profiling Reveals Treatment Modality-Specific Predictors of Biochemical Recurrence In Localized Prostate Cancer
Speaker: Ahmed El-Sehemy, MD - University Health Network (UHN), University of Toronto, Toronto -
05:15pm - 05:20pm ET
Assessing MMAI Algorithmic Fairness within Racial and Age Subgroups In NRG/RTOG Post-Radical Prostatectomy Phase III Trials
Speaker: Shalini Moningi, MD - Cleveland Clinic Taussig Cancer Institute, Cleveland -
05:20pm - 05:25pm ET
Real-World Evidence across Prostate RT Modalities: Utilization Shifts, Toxicity and BCR in Genomic Classifier Scored Patients
Speaker: Thomas Kole, MD, PhD - Valley Health System, Paramus -
05:25pm - 05:30pm ET
Phase 2 Trial of Metastasis Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer
Speaker: Rachel Glicksman, MD - University of Toronto, Toronto -
05:30pm - 05:35pm ET
Germline Biomarker Predicts Adverse Events following SBRT to the Prostate Fossa after Radical Prostatectomy
Speaker: Joanne Weidhaas, MD, PhD - UCLA Radiation Oncology, Los Angeles -
05:35pm - 05:55pm ETSpeaker: Michael Goldstein, MD, PhD - Johns Hopkins School of Medicine, Baltimore
-
05:55pm - 06:00pm ETSpeaker: Alan Dal Pra, MD - University of Miami - Sylvester Comprehensive Cancer Center, Miami